Cerom

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cerom

Property Description
Active Ingredient Cefuroxime
Pharmacological Class Second-Generation Cephalosporin Antibiotic
Primary Forms Tablets, Oral Suspension, Powder for Injection
General Purpose Elimination of Bacterial Infections
Origin Synthetic Compound

Defining Cerom: Origin, Composition, and Class

Cerom is a prescription-only medicine that functions as an antibiotic, utilizing the potent substance Cefuroxime as its sole active ingredient. This medication is a synthetic compound specifically classified within the second-generation cephalosporin family, which belongs to the larger class of beta-lactam agents. The specific chemical structure of Cefuroxime is clinically recognized for providing stability against certain bacterial enzymes. Cerom is invariably a single-ingredient product, formulated exclusively to deliver the antimicrobial properties of Cefuroxime.

Physical Forms and Administration Type

The core substance Cefuroxime is prepared in several distinct physical forms to accommodate different clinical needs. Cerom is available as film-coated tablets and an oral suspension for administration by mouth; these forms typically contain the prodrug Cefuroxime axetil, which is optimized for absorption. For situations requiring direct systemic action, it is also manufactured as a sterile powder for injection, containing the salt form Cefuroxime sodium intended for parenteral (intravenous or intramuscular) administration. The availability of both an oral form and a high-efficiency injectable form ensures the medication can be used for a wide range of patient scenarios requiring systemic treatment.

Core Purpose and Mechanism Type

The fundamental purpose of Cerom is the elimination of active bacterial infections in the body, such as typical respiratory or skin infections. Cefuroxime functions as a bactericidal agent. This means it actively destroys susceptible bacterial pathogens, rather than simply inhibiting their reproduction. Additionally, the drug’s properties classify it as a broad-spectrum agent, confirming the medicine is effective against a wide variety of bacterial organisms encountered in general practice.

Regulatory References

  1. World Health Organization (WHO)

What side effects are possible with Cerom?

Possible Side Effects and Safety Information

The information below outlines the officially documented adverse reactions and safety constraints of Cefuroxime (Cerom), based on government regulatory documents such as the FDA Prescribing Information and the EMA Summary of Product Characteristics.

Adverse Reaction Scope

The drug's safety profile includes a range of reactions formally categorized by frequency and the body system affected.

Classification Examples (from Regulatory Data)
Common (1% to <10%) Diarrhea, Nausea, Vomiting, Headache, Dizziness, Eosinophilia, Transient increases of hepatic enzyme levels.
Uncommon (0.1% to <1%) Positive Coombs' Test, Thrombocytopenia (low platelet count), Leukopenia (low white blood cell count).

Adverse effects are grouped into System-Organ-Classes (SOCs), including Gastrointestinal Disorders, Blood and Lymphatic System Disorders, Immune System Disorders, and Nervous System Disorders.

Serious Adverse Reactions and Restrictions

Official labeling defines several serious risks. These include potentially fatal Serious Hypersensitivity Reactions (e.g., Anaphylaxis) and Severe Cutaneous Adverse Reactions (SCARs). Additionally, Clostridioides difficile-Associated Diarrhea (CDAD), which can be severe, is a documented risk, sometimes occurring up to two months after the medication is discontinued. Seizures have also been reported, particularly in patients with kidney impairment whose dosage was not adjusted.

Cerom is contraindicated in individuals with a known history of severe hypersensitivity to Cefuroxime or other beta-lactam antibiotics. Safety notes also exist for special populations: the total daily dose must be reduced for patients with Renal Impairment due to prolonged drug clearance, and the oral suspension form carries a warning for patients with Phenylketonuria (PKU) as it contains phenylalanine.

Overdose and Emergency Response

Overdose Manifestations and Risks

The official regulatory documentation for Cefuroxime (Cerom) identifies neurotoxicity as the primary risk associated with overexposure. Severe central nervous system effects, including convulsions and seizures, are the most significant documented overdose manifestations. Encephalopathy has also been reported in association with high systemic concentrations.

The risk of toxic accumulation is increased in patients with renal impairment, as the drug’s primary excretion route is via the kidneys. This accumulation can lead to heightened neurotoxicity. Older age groups are also cited as a potential risk factor for severe effects.

Emergency Actions and Required Management

Regulatory guidance mandates that individuals seek immediate medical attention for any suspected overdose. It is required to contact a Poison Control center immediately. Furthermore, urgent emergency services must be called if the individual has collapsed, experiences a seizure, has trouble breathing, or cannot be awakened.

No specific antidote is known for Cerom overdose. The officially described management strategy involves symptomatic and supportive treatment and requires the necessary monitoring of vital signs and renal function to manage the systemic exposure.

Therapeutic Uses of Cerom

Cerom is an antibacterial drug commonly used to address active bacterial infections, and supports patients during episodes of heightened discomfort to assist with managing symptoms that create noticeable physiological strain.

The medication is applied across domains where additional symptomatic support is needed to ease the overall symptom burden associated with bacterial presence.

Relief from Acute Bacterial Episodes

Cerom is relevant for managing symptom clusters that may become intense or disruptive in conditions like acute bacterial sinusitis, tonsillitis, otitis media, and pneumonia. It is also applied in contexts where short-term symptomatic assistance is needed for localized infections, including uncomplicated UTIs, specific skin and soft-tissue infections, and early Lyme disease. This application contributes to improved comfort during periods of heightened symptoms.

“The application of Cerom supports patients during difficult symptomatic episodes associated with bacterial presence.”

Support in Specialized Contexts

The medication is commonly used to help with infection prevention in specific surgical contexts. It is also applied in clinical settings that involve acute or unstable symptom patterns, including certain severe infections like septicemia and meningitis.

Quick Fact: Relief for Inflammatory Symptoms Cerom supports the patient by addressing symptoms related to inflammatory or irritative states, such as localized pain, swelling, and fever, contributing to easing the overall symptom load.

Eligibility and Restrictions for Use

The authoritative eligibility and non-eligibility profile for Cerom is based strictly on the formal regulatory documents, such as the FDA-approved Prescribing Information (US) or the EMA Summary of Product Characteristics (EU).

As specific, official labeling for Cerom is not publicly detailed in this context, the population who can and cannot use the drug is currently undefined by governmental regulatory statements. The following classifications are used by regulators to define the final eligibility structure:

  • Populations for whom use is contraindicated: Contraindication statements legally prohibit the use of a medicine in specific patient groups (e.g., due to a known, serious risk). No formal contraindications for Cerom are documented in the available regulatory snippets.
  • Special Population Restrictions: Regulatory agencies require specific data for use in vulnerable populations. Eligibility statements regarding age (pediatric use), organ impairment (hepatic or renal), and physiological states (pregnancy/lactation) are established when applicable to ensure safe use. No specific restrictions for Cerom are documented in the available snippets.

The final determination of eligibility and non-eligibility for Cerom rests with the official governmental label, which details the permitted populations and any limitations, such as those with certain clinical conditions.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of Cerom (Cefuroxime) is defined by pharmacokinetic effects that modify drug exposure and pharmacodynamic effects that introduce additive risks, as documented in official regulatory labeling.


Official Pharmacokinetic Interactions

Co-administration of Probenecid with Cerom significantly increases and prolongs Cefuroxime plasma concentrations. This effect is attributed to the inhibition of the renal clearance mechanism. Due to the increased systemic exposure, this combination is typically noted as not recommended in prescribing information.

Conversely, drugs that reduce gastric acidity, such as antacids and proton pump inhibitors (acid-reducing agents), can significantly lower the bioavailability of the oral form, Cefuroxime axetil, resulting in reduced peak plasma concentrations. Administration of acid-reducing agents should be restricted to avoid this reduction in exposure. The absorption of oral Cefuroxime axetil is, however, enhanced by food.


Pharmacodynamic and Procedural Interactions

Combinations with other medicinal products may introduce additive risks. Concomitant use with oral anticoagulants carries a potential for an increased International Normalized Ratio (INR). Additionally, the combination of Cerom with other known nephrotoxic agents, such as aminoglycosides or potent diuretics, carries an officially documented additive risk of nephrotoxicity.

Cefuroxime may also interfere with certain diagnostic tests, including causing a false-positive result in copper reduction tests for urine glucose and potentially the direct Coombs test.

Mechanism of Action

Cefuroxime is classified as a bactericidal agent that acts by disrupting the essential structural integrity of susceptible bacteria, resulting in cell lysis. Its mechanism is highly specific, focusing on two central pharmacodynamic domains.

Irreversible Blockade of Bacterial Cell Wall Formation

This mechanism centers on the drug's role as an irreversible inhibitor of bacterial Penicillin-Binding Proteins (PBPs), a class of enzymes responsible for assembling the rigid outer envelope of the bacterial cell. By forming a strong, permanent bond with these enzymes, Cefuroxime halts the crucial process of peptidoglycan cross-linking. This failure to correctly form the cell wall subjects the bacterium to internal osmotic pressure, which triggers cell lysis (rupture).


Mechanistic Stability Against Bacterial Defense Enzymes

Cefuroxime's structure provides stability against common beta-lactamases, defense enzymes produced by certain bacteria that can chemically degrade the antibiotic. This molecular property allows the drug to effectively engage the bactericidal cascade in environments with beta-lactamase activity, resulting in the elimination of susceptible organisms.

Dosage and Administration Information

Official Administration Guidelines

Cefuroxime (Cerom) is officially administered via three approved routes: oral (tablets and suspension), intravenous (IV), and intramuscular (IM) injection. The parenteral form (IV/IM) requires reconstitution of a sterile powder prior to use.

Standard Dosing and Frequency

The typical adult oral dose ranges from 250 mg to 500 mg, generally taken twice daily (every 12 hours). For severe systemic infections, the parenteral dose usually ranges from 750 mg to 1.5 g, administered three times daily (every 8 hours). The total course duration for most infections is 7 to 10 days, although certain conditions, such as early Lyme disease, may require up to 20 days of treatment.

Contextual Intake Conditions

Administration conditions depend on the specific form. The oral suspension must be consumed with food to ensure optimal absorption. Conversely, tablets may be taken with or without food. A mandatory procedural instruction is that tablets must be swallowed whole and should not be crushed, broken, or chewed. The IV/IM route often utilizes sequential therapy, beginning with the injection and transitioning to the oral form to complete the course.

Special Adjustments

Dose adjustment is officially required for patients with confirmed renal impairment, where the dosing interval must be prolonged to prevent drug accumulation. The tablet and oral suspension forms are not bioequivalent and cannot be substituted on a milligram-for-milligram basis.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Cerom

This overview describes the types of scientific studies that have evaluated the medicine Cerom (Cefuroxime) according to regulatory and authoritative peer-reviewed sources. It focuses on the nature of the research, the populations studied, and the evidence gaps, without offering any clinical advice or interpretation.


Evidence for Use in Respiratory and Ear Infections

The body of evidence for the medicine was studied for common infections like Acute Otitis Media (AOM), Pharyngitis/Tonsillitis, and Lower Respiratory Tract Infections and includes Randomized Controlled Trials (RCTs) and meta-analyses. These studies monitored outcomes related to physical discomfort and outcomes reflecting daily functioning or activity level, such as how symptoms evolved and whether studies monitored the clearance of the targeted bacteria. For infections such as AOM in children, research examined how symptoms evolved in the observed populations, and reported outcomes were described based on predefined measurement criteria when compared to other treatments. Few data are available for the use of the medicine in infants younger than three months of age for conditions like AOM.


Evidence for Use in Serious Systemic Infections and Surgical Prevention

Evidence for severe clinical situations like Septicemia and Meningitis includes comparative efficacy trials that monitored high-stakes outcomes, including survival rates and the sterilization of body fluid cultures. Reported data indicated that the drug concentrations in the Cerebrospinal Fluid (CSF) were generally lower when compared to some third-generation cephalosporins, a factor noted in the research. Certainty remains low for the use of this medicine against some of the newest, most resistant pathogens.


Long-Term Research and Limitations

Studies for Cerom have primarily been designed to assess short-term symptom changes, with typical follow-up durations ranging from ten to thirty days post-treatment. While research provides insight into short-term changes, the long-term effects are not fully established for every studied condition. An exception is the research for Early Lyme Disease, where studies tracked patients for up to a year to confirm the absence of long-term manifestations. Limitations include modest sample sizes in some specific patient groups and inconsistent findings in certain studies focusing on non-bacterial causes of illness.

Key Studies & References

  1. Cefuroxime Axetil Tablet, Film Coated and Oral Suspension Label Information (DailyMed)

Frequently Asked Questions (FAQ)

Common questions about Cerom (FAQ)


Q: How quickly should I expect to feel the effects of Cerom?

According to official patient information, if the medicine is working, you should typically begin to feel better within the first few days of treatment. It is generally recommended to complete the full prescribed course of treatment, even if symptoms improve quickly.


Q: Does Cerom cause weight gain or weight loss?

Weight loss is noted as a rare side effect in some post-marketing reports for the active ingredient in Cerom. Weight gain is not commonly listed as an adverse reaction in official product labeling.


Q: Is it normal to feel a bit sleepy when starting Cerom?

Sleepiness or unusual drowsiness is listed as an uncommon side effect in regulatory documents. Common nervous system side effects include headache and dizziness, and caution should be exercised when driving or operating machinery if these effects are experienced.


Q: What happens if I accidentally miss a dose of Cerom?

If a dose is missed, official patient counseling information generally advises taking it as soon as it is remembered. However, if it is nearly time for your next scheduled dose, skip the missed one entirely. It is advised not to take a double dose to make up for a missed dose.


Q: Are there any specific foods or drinks I need to avoid while on Cerom?

Regulatory documents do not list specific foods or non-alcoholic drinks that must be avoided while using Cerom. For the oral suspension form, taking the medicine with food is generally recommended as it is known to help improve absorption.


Q: Can Cerom affect my blood pressure or heart rate?

An increase in heart rate, known as Tachycardia, is listed as an uncommon adverse reaction in some reports within official safety data. The regulatory label does not specifically list changes to blood pressure as a common or uncommon side effect.


Q: How long does Cerom stay in your system after you stop taking it?

According to the pharmacokinetics section of the official label, the mean elimination half-life is approximately 1.2 to 1.4 hours in healthy adults. This measure describes the time it takes for half of the drug to be cleared from the body.


Q: Does Cerom require a special diet or lifestyle change to work effectively?

Official patient information indicates that no special diet or lifestyle changes beyond the instructions for taking the medicine (such as taking the suspension with food) are generally required. Continue your normal diet unless otherwise instructed by a healthcare professional.


Q: Is there a generic version of Cerom available, and is it the same?

The active ingredient, Cefuroxime axetil, is available in generic form. However, the regulatory label notes that the tablet and oral suspension forms are not bioequivalent, meaning they are not considered interchangeable on a milligram-per-milligram basis.


Q: What should I do if I experience mild stomach upset after taking Cerom?

Mild stomach upset, such as nausea or vomiting, is a common side effect of Cerom. If stomach upset occurs, regulatory information for the tablet form suggests that taking it with food may help ease the discomfort. If side effects are severe, concerning, or persistent, it is important to seek guidance from a healthcare provider.


Q: What is the maximum duration of treatment with Cerom before needing a break?

Cerom is prescribed for short-term use, and the duration is determined by the specific infection being treated. Most standard courses last between 7 to 10 days, but treatment can last up to 20 days for specific conditions like early Lyme disease.


Q: What age group is Cerom generally approved for?

The medicine is officially indicated for use in adults and in children starting from the age of three months for specific infections. Dosing is adjusted based on the patient's age and weight.


Q: Is there a certain time of day that is best for taking Cerom?

Patient information states that Cerom is usually taken every 12 hours. For consistency, it is suggested to take the medicine at around the same times every day.


Q: Are there any known issues with taking Cerom if you have diabetes?

Official warnings note that Cefuroxime can interfere with certain types of urine glucose tests (copper reduction tests), which may cause a false-positive result. Patients with diabetes should discuss alternative testing methods with their doctor.


Q: Where can I find reliable, official information about Cerom?

Reliable and authoritative information can be found in government-issued documents. These include the FDA-approved Prescribing Information (often hosted on DailyMed) and the Summary of Product Characteristics (SmPC) issued by the European Medicines Agency (EMA).


Q: Will Cerom interfere with the effectiveness of birth control pills?

Official drug interaction information indicates that the active ingredient in Cerom may affect the gut bacteria, which may potentially lead to reduced efficacy of combined oral contraceptives (birth control pills).


Q: How long do the therapeutic effects of a single dose of Cerom last?

While the drug has a short half-life of approximately 1.2 to 1.4 hours, the drug is typically administered every 12 hours to help maintain the required concentration in the body throughout the dosing period.


Q: Is Cerom a long-term treatment or just for short-term use?

Cerom is prescribed for short-term use to treat active bacterial infections. Treatment courses typically last between 7 and 20 days, depending on the infection.


Q: What are the common reasons doctors might discontinue Cerom treatment?

Official warnings list several reasons for discontinuation, such as the onset of severe adverse reactions (like anaphylaxis or severe diarrhea) or when the patient is suspected of developing an infection that is not susceptible to the drug.


Q: Does Cerom affect my mood or mental clarity?

Adverse effects related to the Central Nervous System (CNS) are reported in the official label, including common effects like headache and dizziness, and uncommon reports of sleepiness. Due to these effects, there is a potential for temporary impact on alertness.


Q: Is Cerom safe for use during all stages of pregnancy?

The official prescribing information indicates that the drug's safety in human pregnancy has not been fully established through adequate studies. Its use during pregnancy is typically considered when the expected benefit is determined to outweigh the potential risk.


Q: How can I tell if Cerom is actually working for my condition?

Official patient information states that a sign the medicine is working is when you begin to feel better during the first few days of treatment. If symptoms do not improve or if they worsen, it is important to seek guidance from a healthcare provider.


Q: Is Cerom considered a 'new' drug, or has it been around for a while?

The active ingredient, Cefuroxime, is classified as a second-generation cephalosporin, an established class of antibiotics. The drug received its initial approval in the U.S. in 1987.


Q: Can older adults safely use Cerom, or are there special precautions?

Official regulatory information notes that older adults (65 years and older) should use the medicine with caution as they may be more susceptible to side effects. While a dose adjustment based on age alone is not required, kidney function must be closely monitored.


Q: Does taking Cerom affect my ability to drive or operate machinery?

Regulatory documents explicitly state that this medicine may cause dizziness. Patients are advised to exercise caution when performing tasks that require mental alertness, such as driving or operating machinery, due to this risk.


Q: What makes Cerom a unique treatment option compared to alternatives?

The official microbiology data highlights that the drug's chemical structure provides stability against certain bacterial defense enzymes called beta-lactamases. This property helps the medicine remain effective in environments where certain bacterial defenses are present.


Q: Are there any studies or research papers that explain the long-term effects of Cerom?

Studies have primarily been designed to assess short-term changes in symptoms, and long-term effects are not fully established for every studied condition. However, some studies for Early Lyme Disease tracked patients for up to one year to assess long-term outcomes.


Q: Does the effectiveness of Cerom decrease over time (tolerance)?

The regulatory label addresses the risk of microbial overgrowth by non-susceptible organisms, known as superinfection, which can make the drug seem less effective. It also warns about the risk of promoting the development of drug-resistant bacteria.


Q: What kind of studies support the efficacy of Cerom for its main uses?

The efficacy (effectiveness) of Cerom is supported by controlled clinical trials, including randomized controlled trials (RCTs). These studies tracked outcomes related to the improvement of symptoms and the clearance of the targeted bacteria.

How should Cerom be stored and disposed of?

The official storage and disposal instructions for Cerom (Cefuroxime) are determined by its specific formulation to ensure stability and quality.

Storage Conditions

  • Tablets must be stored at controlled room temperature, typically 20 C to 25 C, and kept in the original packaging to protect from moisture.
  • Powder for Injection must be stored between 15 C and 30 C and kept in the outer carton to protect from light.
  • Reconstituted oral suspension is stable for up to 14 days when stored under refrigeration (2 C to 8 C) and must be discarded after this period.

Handling and Safety

All forms of Cerom must be stored out of the sight and reach of children.

Disposal Requirements

Any unused or expired medicine must be disposed of in accordance with local regulatory requirements for pharmaceutical waste. Solutions and suspensions must be discarded after their labeled in-use stability periods.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cerom found in:

A-Z Index: